Trillions of microbes live in the digestive tract alone, affecting health in digestion, metabolism, and immune response. Antibiotics can harm the microbiome, leading to secondary health issues.
Researchers aim to develop antibiotics that target only harmful bacteria, sparing the beneficial microbiome. Lolamicin, an antibiotic compound, effectively kills drug-resistant pathogens while preserving the microbiome in mice.
Collection
[
|
...
]